| 1. |
Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol, 2018, pii: S0735-1097(18)38985-X.[Epub ahead of print].
|
| 2. |
Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. Circulation, 2018, 6:CIR0000000000000628.[Epub ahead of print].
|
| 3. |
Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. Heart Rhythm, 2018, pii: S1547-5271(18)31127-5.[Epub ahead of print].
|
| 4. |
Puskas JD, Sharoni E, Williams WH, et al. Is routine use of temporary epicardial pacing wires necessary after either OPCAB or conventional CABG/CPB? Heart Surg Forum, 2003, 6(6): E103-E106.
|
| 5. |
Garcia-Bengochea JB, Fernandez AL, Calvelo DS, et al. Temporary epicardial left ventricular and biventricular pacing improves cardiac output after cardiopulmonary bypass. J Cardiothorac Surg, 2012, 7: 113.
|
| 6. |
Russell SJ, Tan C, O'Keefe P, et al. Optimized temporary bi-ventricular pacing improves haemodynamic function after on-pump cardiac surgery in patients with severe left ventricular systolic dysfunction: a two-centre randomized control trial. Eur J Cardiothorac Surg, 2012, 42(6): e146-e151.
|
| 7. |
Evonich RF, Stephens JC, Merhi W, et al. The role of temporary biventricular pacing in the cardiac surgical patient with severely reduced left ventricular systolic function. J Thorac Cardiovasc Surg, 2008, 136(4): 915-921.
|
| 8. |
Bethea BT, Salazar JD, Grega MA, et al. Determining the utility of temporary pacing wires after coronary artery bypass surgery. Ann Thorac Surg, 2005, 79(1): 104-107.
|
| 9. |
Imren Y, Benson AA, Oktar GL, et al. Is use of temporary pacing wires following coronary bypass surgery really necessary? J Cardiovasc Surg (Torino), 2008, 49(2): 261-267.
|
| 10. |
Baraki H, Al Ahmad A, Jeng-Singh S, et al. Pacemaker dependency after isolated aortic valve replacement: do conductance disorders recover over time? Interact Cardiovasc Thorac Surg, 2013, 16(4): 476-481.
|
| 11. |
Schurr UP, Berli J, Berdajs D, et al. Incidence and risk factors for pacemaker implantation following aortic valve replacement. Interact Cardiovasc Thorac Surg, 2010, 11(5): 556-560.
|
| 12. |
Indik JH, Gimbel JR, Abe H, et al. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm, 2017, 14(7): e97-e153.
|
| 13. |
McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg, 2004, 127(3): 674-685.
|
| 14. |
de Cock CC, Vinkers M, Van Campe LC, et al. Long-term outcome of patients with multiple (> or = 3) noninfected transvenous leads: a clinical and echocardiographic study. Pacing Clin Electrophysiol, 2000, 23(4 Pt 1): 423-426.
|
| 15. |
Eleid MF, Blauwet LA, Cha YM, et al. Bioprosthetic tricuspid valve regurgitation associated with pacemaker or defibrillator lead implantation. J Am Coll Cardiol, 2012, 59(9): 813-818.
|
| 16. |
Abu-El-Haija B, Bhave PD, Campbell DN, et al. Venous stenosis after transvenous lead placement: a study of outcomes and risk factors in 212 consecutive patients. J Am Heart Assoc, 2015, 4(8): e001878.
|
| 17. |
Michaelsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. a prospective study. Circulation, 1995, 92(3): 442-449.
|
| 18. |
Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med, 2001, 135(12): 1061-1073.
|
| 19. |
Gillinov AM, Bagiella E, Moskowitz AJ, et al. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med, 2016, 374(20): 1911-1921.
|
| 20. |
Levine SA, Miller H, Penton GB. Some clinical features of complete heart block. Circulation, 1956, 13(6): 801-824.
|
| 21. |
Echahidi N, Pibarot P, O'Hara G, et al. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol, 2008, 51(8): 793-801.
|
| 22. |
Kiehl EL, Makki T, Matar RM, et al. Incidence and predictors of late atrioventricular conduction recovery among patients requiring permanent pacemaker for complete heart block after cardiac surgery. Heart Rhythm, 2017, 14(12): 1786-1792.
|
| 23. |
Cook DJ, Bailon JM, Douglas TT, et al. Changing incidence, type, and natural history of conduction defects after coronary artery bypass grafting. Ann Thorac Surg, 2005, 80(5): 1732-1737.
|
| 24. |
Gillinov AM, Gelijns AC, Parides MK, et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med, 2015, 372(15): 1399-1409.
|
| 25. |
Ad N, Suri RM, Gammie JS, et al. Surgical ablation of atrial fibrillation trends and outcomes in North America. J Thorac Cardiovasc Surg, 2012, 144(5): 1051-1060.
|
| 26. |
Saint LL, Damiano RJ Jr, Cuculich PS, et al. Incremental risk of the Cox-maze IV procedure for patients with atrial fibrillation undergoing mitral valve surgery. J Thorac Cardiovasc Surg, 2013, 146(5): 1072-1077.
|
| 27. |
Gammie JS, Haddad M, Milford-Beland S, et al. Atrial fibrillation correction surgery: lessons from the society of thoracic surgeons national cardiac database. Ann Thorac Surg, 2008, 85(3): 909-914.
|
| 28. |
Phan K, Xie A, La Meir M, et al. Surgical ablation for treatment of atrial fibrillation in cardiac surgery: a cumulative meta-analysis of randomised controlled trials. Heart, 2014, 100(9): 722-730.
|
| 29. |
Elahi MM, Lee D, Dhannapuneni RR. Predictors of permanent pacemaker implantation during the early postoperative period after valve surgery. Tex Heart Inst J, 2006, 33(4): 455-457.
|
| 30. |
Leyva F, Qiu T, McNulty D, et al. Long-term requirement for pacemaker implantation after cardiac valve replacement surgery. Heart Rhythm, 2017, 14(4): 529-534.
|
| 31. |
Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. JACC Cardiovasc Interv, 2015, 8(1 Pt A): 60-69.
|
| 32. |
Roten L, Wenaweser P, Delacretaz E, et al. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol, 2010, 106(10): 1473-1480.
|
| 33. |
Toggweiler S, Stortecky S, Holy E, et al. The electrocardiogram after transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring. JACC Cardiovasc Interv, 2016, 9(12): 1269-1276.
|
| 34. |
Liebregts M, Vriesendorp PA, Mahmoodi BK, et al. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. JACC Heart Fail, 2015, 3(11): 896-905.
|
| 35. |
Poon SS, Field M, Gupta D, et al. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy? Interact Cardiovasc Thorac Surg, 2017, 24(6): 951-961.
|
| 36. |
Qin JX, Shiota T, Lever HM, et al. Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. Am J Cardiol, 2004, 93(2): 171-175.
|
